Baker Bros. Advisors’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $13.6M | Hold |
|
|||||
|
2022
Q3 | $7.6M | Hold |
|
|||||
|
2022
Q2 | $6.4M | Hold |
|
|||||
|
2022
Q1 | $6.75M | Hold |
|
|||||
|
2021
Q4 | $7.34M | Hold |
|
|||||
|
2021
Q3 | $7.92M | Hold |
|
|||||
|
2021
Q2 | $9.46M | Hold |
|
|||||
|
2021
Q1 | $9.85M | Sell |
|
|||||
|
2020
Q4 | $16.6M | Sell |
|
|||||
|
2020
Q3 | $23.5M | Buy |
|
|||||
|
2020
Q2 | $5.32M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $29.2M | Hold |
|
|||||
|
2019
Q2 | $40.9M | Hold |
|
|||||
|
2019
Q1 | $75.8M | Buy |
|
|||||
|
2018
Q4 | $38.7M | Hold |
|
|||||
|
2018
Q3 | $54.5M | Hold |
|
|||||
|
2018
Q2 | $66M | Buy |
|
|||||
|
2018
Q1 | $50.9M | Buy |
|
|||||
|
2017
Q4 | $27.5M | Hold |
|
|||||
|
2017
Q3 | $24.1M | Buy |
|
|||||
|
2017
Q2 | $7.44M | Sell |
|
|||||
|
2017
Q1 | $6.08M | Buy |
|
|||||
|
2016
Q4 | $535K | Buy |
|